Search Kailos website
David Dubin, VP of Sales for Kailos Genetics, co-founder of AliveandKickn, and Lynch syndrome survivor speaks about the importance and utility of hereditary cancer screening. Please visit our ExpedioTM Hereditary Cancer Testing page or contact us for more information.
October 20, 2020
Breast cancer is prevalent in the United States, and many people have relatives that have been diagnosed with the disease. While the vast majority of breast cancer cases are considered sporadic, or not caused by an inherited, adverse change (mutation) in a gene, approximately five to ten percent of breast cancer cases are hereditary and can be passed from an affected parent to their child.1
A young woman, new to your practice, is in for a routine physical. Her family history of cancer includes her mother, who was diagnosed with breast cancer at age 45, and her maternal grandmother, who was diagnosed with ovarian cancer. While positive cancer diagnoses in both a mother and maternal grandmother do not necessarily indicate the presence of hereditary cancer, several hereditary cancer syndromes are known to increase the risk of both breast and ovarian cancers. With this knowledge, you order comprehensive hereditary cancer genetic testing to determine if there is a gene mutation responsible for the family’s cancer history. The...
BIRMINGHAM, Ala. — August 2020 — Two Alabama-based organizations are partnering to find cures for common diseases that cause blindness for millions of people worldwide.
October 13, 2020
About one in every eight women in the United States will be diagnosed with an invasive breast cancer in her lifetime, making breast cancer the second most common cancer diagnosed in women.1
Kailos Genetics, a CLIA-certified genetic sequencing company, announced they have entered into a partnership with Intermountain Healthcare to establish a pharmacogenetic testing platform for the healthcare network.